Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenocarcinoma × Ipilimumab × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 50 Carcinoma, Renal Cell 14 Neoplasm Metastasis 13 Neoplasms 12 Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Uveal Melanoma 8 Pancreatic Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Lymphoma 7 Leukemia, Myeloid, Acute 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Carcinoma, Hepatocellular 7 Sarcoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Myelodysplastic Syndromes 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Recurrence 4 Neuroblastoma 4 Myeloproliferative Disorders 4 Lymphoma, Large B-Cell, Diffuse 4 Lung Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Kidney Neoplasms 4 Hodgkin Disease 4

Interventions

Fluorouracil 9 Gemcitabine 7 pembrolizumab 6 Irinotecan 6 Paclitaxel 5 Leucovorin 5 Carboplatin 5 Nivolumab 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Albumin-Bound Paclitaxel 3 vandetanib 2 spartalizumab 2 selinexor 2 osimertinib 2 folfirinox 2 Taxes 2 Ramucirumab 2 Radiation 2 Docetaxel 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 zolbetuximab 1 trastuzumab deruxtecan 1 trametinib 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04315155 2020-10-28

BENEFIT

University of Utah

Phase 1 Withdrawn

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡